Treco Douglas A insider trades
Treco Douglas A has filed 15 Form 4s with the SEC that we hold, for INZY (CEO & Chairman, Director) and CRISPR Therapeutics AG (CRSP) (Director). Across all of them we count 1 purchase worth $1.1M and 2 sales worth $60.1K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 20,000 shares of CRISPR Therapeutics AG worth $1.1M, dated 2025-08-06. The first filing on our record is dated 2022-06-10 and the latest 2026-06-09.
INZY
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-04-02 | S, sale reported on Form 4 | 7,523 | $52.2K | 2024-04-03 |
| 2025-04-02 | S, sale reported on Form 4 | 8,819 | $7.8K | 2025-04-03 |
CRISPR Therapeutics AG (CRSP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-08-06 | P, purchase reported on Form 4 | 20,000 | $1.1M | 2025-08-08 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1688192) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms